Cramer Weighs In On Baidu, Clorox And More
On CNBC's "CNBC's "Mad Money Lightning Round," Jim Cramer said he's not going to fight Reinvent Technology Partners (NYSE: RTP) because this SPAC is below $10.
50 Biggest Movers From Yesterday
Gainers
Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share.